Last update:
Medications news
Medications
Study exposes huge levels of untargeted antibiotic prescribing
Doctors are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of prognosis and the risk of the infection worsening, according to a new study led by University of Manchester ...
12 hours ago
0
61
Medications
A failed fragile X syndrome drug can reduce cocaine use, clinical trial finds
A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has found that the drug mavoglurant can reduce use in people with cocaine use disorder. In their study, ...
20 hours ago
0
74
AI-powered database spotlights medication risks to improve drug safety
A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in the United States and a medical issue costing more than $500 billion annually.
20 hours ago
0
9
Q&A: How can drug repurposing lower drug costs and improve care?
Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United States topped $722 billion, a trend that's expected to continue. Yet, nearly 30% struggle to pay for their prescriptions ...
16 hours ago
0
0
Robots can aid hospital pharmacies in safer and more sustainable cancer drug preparation
Can a robot help prepare cancer medication in a hospital pharmacy? That's what hospital pharmacist Tjerk Geersing investigated in his Ph.D. research. He compared manual and automated preparations in terms of quality, efficiency, ...
16 hours ago
0
0
FDA approves Qfitlia to cut bleeding episodes in patients with hemophilia
The U.S. Food and Drug Administration has approved Sanofi's Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with ...
21 hours ago
0
0
New COVID-19 drug shows greater promise against resistant viral strains
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment.
Apr 2, 2025
0
166
Use of last-resort antibiotics increased during COVID-19 pandemic
A new study by researchers from City St George's, University of London and the Ineos Oxford Institute for antimicrobial research, has found that prescriptions of last-resort antibiotics increased across multiple countries ...
Apr 2, 2025
0
0
Common photosensitizing drugs increase skin cancer risk, study indicates
Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.
Apr 2, 2025
0
0
Novel Alzheimer's drug candidate reduces inflammation and protects neurons
Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease. A team from the University of Barcelona has developed ...
Apr 1, 2025
0
61
Trade tariffs on Canadian pharmaceuticals expected to increase costs in the US and strain drug supply chains
Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to new research findings from the University of Toronto. Applying 25% trade tariffs to these pharmaceuticals ...
Apr 1, 2025
0
26
An important step forward in developing new treatment for E. coli infections
Scientists have taken an important step toward the development of a potential new treatment for treating Shiga toxin-producing E. coli (STEC), the notorious bug associated with severe food poisoning.
Apr 1, 2025
0
0
Blood cancer patients on Bruton's tyrosine kinase inhibitors should continue at time of COVID-19 vaccination, study says
Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 vaccinations, a new study suggests.
Apr 1, 2025
0
0
Stimulant involvement in opioid OD death higher for those in physically demanding jobs
A higher percentage of individuals who have psychostimulant involvement in synthetic opioid overdose deaths tend to work in physically demanding occupations and industries, according to research published in the March 27 ...
Apr 1, 2025
0
0
Alternate antidepressant not effective for Alzheimer's agitation, trial finds
Up to 60% of people with Alzheimer's disease experience agitation, a symptom that can be a significant burden for caregivers. Nondrug treatments are recommended as first-line interventions. Citalopram, a selective serotonin ...
Apr 1, 2025
0
0
New drug may cut sudden heart risk by 94%
A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the blood.
Mar 31, 2025
0
90
Low-dose apixaban comparable to full dose for preventing venous thromboembolism recurrence in patients with cancer
Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of low-dose apixaban, experienced ...
Mar 31, 2025
0
0
Tirzepatide benefits people with obesity, kidney disease and heart failure
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to featured clinical ...
Mar 31, 2025
0
3
Phase 2 trial reveals potential of DPP-1 inhibitor for bronchiectasis
In March 2025, The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by Academician Nan-shan Zhong and Professor Wei-jie Guan from the First Affiliated ...
Mar 31, 2025
0
0
Lorundrostat lowers blood pressure compared with placebo at 12 weeks
Among patients with uncontrolled hypertension, the investigational drug lorundrostat brought a significant reduction in blood pressure at 12 weeks compared with placebo, according to a study presented at the American College ...
Mar 31, 2025
0
0
FDA approves cabozantinib for previously treated advanced neuroendocrine tumors
The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients with previously treated advanced neuroendocrine tumors, offering a new standard of care for this ...
Mar 31, 2025
0
0
Rivaroxaban comparable to warfarin in left ventricular blood clots
At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar patients who received standard ...
Mar 31, 2025
0
0
Clopidogrel outperforms aspirin monotherapy following percutaneous coronary intervention
People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel rather than aspirin as ...
Mar 31, 2025
0
0
Use of antidepressant medication linked to substantial increase in risk of sudden cardiac death
Sudden cardiac death (SCD) refers to an unexpected death of a person, believed to be caused by a heart-related issue. It occurs within one hour of the onset of symptoms in witnessed cases or within 24 hours of the person ...
Mar 30, 2025
0
44
Testing for just three genes could help prevent 75% of avoidable side effects for certain medications
A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect risk is partly dependent ...
Mar 27, 2025
0
66
